A Phase 2b Study of SPI-1005 to Prevent Acute Noise Induced Hearing Loss

Clinical trial NCT02779192 · WITHDRAWN

Trial details

NCT number: NCT02779192
Sponsor: Sound Pharmaceuticals, Incorporated
Status: WITHDRAWN
Phase: Phase 2
Study type: INTERVENTIONAL

Noise Induced Hearing Loss

Start date: 2026-06-01
Primary completion: 2026-06-01
Enrollment: 0

View on ClinicalTrials.gov

Track trials programmatically

Sponsors, conditions and status changes through the Atlas API.